Treatment of human viral infections
Patent 4724232 Issued on February 9, 1988. Estimated Expiration Date: 
September 17, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 17, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsApplicationNo. 06/776899 filed on 09/17/1985US Classes:514/50, 2,4-diketone pyrimidine or derivative (e.g., uracil, etc.)424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/464, Tablets, lozenges, or pills514/51, Phosphorus containing536/28.2, Multideoxy or didehydro536/28.54Alkyl, or substituted alkyl, bonded directly to the 5-position of the diazine ring (e.g., thymidine, 5-methyl uridine, etc.)ExaminersPrimary: Brown, J. TravisAssistant: Rollins, John W. Attorney, Agent or FirmInternational ClassesA61K 38/21 (20060101)C07H 19/06 (20060101) C07H 19/00 (20060101) C07H 19/10 (20060101) Foreign Application Priority Data1985-03-16 GBAbstractTreatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Other References
|
| ||||||||||||||
